Boehringer Ingelheim France, France
| Държава: | Франция |
| Кратка информация: | Value through Innovation is our Corporate Vision The Boehringer Ingelheim group of companies´ objectives and believes can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Together with our corporate culture concept "Lead & Learn", this vision is the driver of our corporate culture. A new vision for a new world Our corporate vision - "Value through Innovation": The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us to build on our strengths and make the most of our distinctive character. In a competitive and fast-changing world, the value of products, services and companies is constantly changing. Real customer value today can only be created by constantly developing new solutions and doing what we already do better. Lead & Learn: The present phase in our evolution is Lead & Learn. Since 2004, it outlines ways in which Boehringer Ingelheim realises and delivers Value through Innovation. As our corporate culture, Lead & Learn is about all the people at Boehringer Ingelheim and how they work together. A new vision for the corporate culture: Lead & Learn superseded the concept of Vision & Leadership that was established in 1993 by the Shareholders and the Board of Managing Directors of the Boehringer Ingelheim corporation. The Vision, created for Boehringer Ingelheim worldwide, was built around the corporate vision of Value through Innovation. Since then, our corporate culture always was guided by this vision. A worldwide group of companies Boehringer Ingelheim is a worldwide operating affiliated group of companies with 42,224 employees. Get an overview of the organisation structure and our two main business areas: Human Pharmaceuticals and Animal Health. Our business areas Our Human Pharmaceuticals business area covers the segments Prescription Medicines Consumer Health Care Biopharmaceuticals Operations (Pharma Production and Chemical Production) In Animal Health, our core business segments serve food-producing and companion animals. Overview companies Boehringer Ingelheim companies In 1993, the Shareholders and the Board of Managing Directors of the Boehringer Ingelheim Corporation formulated a vision for Boehringer Ingelheim worldwide, built around the central concept of our Corporate vision "Value through Innovation". Overview of the major consolidated companies - PDF (47 KB) Boehringer Ingelheim Take-away info Financial Highlights The history of Boehringer Ingelheim: A tradition of innovation The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. From its beginnings in 1885 when it employed just 28 people in Nieder-Ingelheim, the company has since become a global enterprise. As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. |
| Сайт: | http://www.boehringer-ingelheim.com/global_activities/europe/france.html |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
